[Possibilities and limitations of influencing concentration disorders in school children with organic brain-induced reduced achievement capabilities].
D000085:Acetates / Q000627:therapeutic use*; D000124:Achievement; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000150:complications; D002648:Child; D002986:Clinical Trials as Topic; D004220:Disulfides / Q000627:therapeutic use; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D007360:Intelligence; D007859:Learning Disabilities / Q000188:drug therapy* / Q000209:etiology; D002504:Meclofenoxate / Q000627:therapeutic use; D009042:Motivation; D009570:Nitriles / Q000627:therapeutic use*; D010919:Placebos; D011437:Propylamines / Q000627:therapeutic use; D011594:Psychometrics; D011596:Psychomotor Disorders / Q000150:complications; D011736:Pyridoxine / Q000627:therapeutic use*
D000085:Acetates; D000697:Central Nervous System Stimulants; D004220:Disulfides; D009570:Nitriles; D010919:Placebos; D011437:Propylamines; D002504:Meclofenoxate; D011736:Pyridoxine
Möglichkeiten und Grenzen der medikamentösen Beeinflussung von Konzentrationsstörungen bei hirnorganisch leistungsgeminderten Schulkindern.